2015 Q2 Form 10-Q Financial Statement
#000119312515178581 Filed on May 08, 2015
Income Statement
| Concept | 2015 Q2 | 2014 Q4 | 2014 Q1 |
|---|---|---|---|
| Revenue | $460.4M | $583.9M | $430.5M |
| YoY Change | -4.44% | 3.26% | 0.04% |
| Cost Of Revenue | $189.2M | $233.1M | $187.7M |
| YoY Change | -6.25% | 1.8% | 7.53% |
| Gross Profit | $271.2M | $350.8M | $242.8M |
| YoY Change | -3.14% | 4.25% | -5.08% |
| Gross Profit Margin | 58.9% | 60.07% | 56.4% |
| Selling, General & Admin | $119.8M | $131.9M | $126.6M |
| YoY Change | -9.23% | 0.95% | 6.72% |
| % of Gross Profit | 44.16% | 37.61% | 52.16% |
| Research & Development | $28.95M | $28.72M | $24.75M |
| YoY Change | 7.32% | 6.48% | -2.24% |
| % of Gross Profit | 10.68% | 8.19% | 10.19% |
| Depreciation & Amortization | $11.45M | $23.60M | $8.819M |
| YoY Change | -44.98% | 9.77% | 3.91% |
| % of Gross Profit | 4.22% | 6.73% | 3.63% |
| Operating Expenses | $148.7M | $160.6M | $151.4M |
| YoY Change | -6.42% | 1.89% | 5.15% |
| Operating Profit | $120.0M | $172.0M | $88.76M |
| YoY Change | 1.34% | -2.35% | -18.87% |
| Interest Expense | $8.975M | $9.669M | $7.489M |
| YoY Change | 12.6% | 21.98% | 4.23% |
| % of Operating Profit | 7.48% | 5.62% | 8.44% |
| Other Income/Expense, Net | $0.00 | ||
| YoY Change | |||
| Pretax Income | $113.3M | $164.5M | $82.73M |
| YoY Change | 1.09% | -2.87% | -20.0% |
| Income Tax | $17.29M | $13.18M | $12.43M |
| % Of Pretax Income | 15.25% | 8.01% | 15.02% |
| Net Earnings | $96.10M | $151.3M | $70.30M |
| YoY Change | -0.41% | 6.85% | -41.95% |
| Net Earnings / Revenue | 20.87% | 25.91% | 16.33% |
| Basic Earnings Per Share | $1.16 | $1.82 | $0.83 |
| Diluted Earnings Per Share | $1.15 | $1.80 | $0.82 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 83.03M shares | 83.22M shares | 84.98M shares |
| Diluted Shares Outstanding | 83.75M shares | 84.02M shares | 85.87M shares |
Balance Sheet
| Concept | 2015 Q2 | 2014 Q4 | 2014 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $2.109B | $2.055B | $1.853B |
| YoY Change | 9.98% | 13.95% | 16.56% |
| Cash & Equivalents | $440.8M | $422.2M | $395.4M |
| Short-Term Investments | $1.668B | $1.633B | $1.458B |
| Other Short-Term Assets | $115.0M | $118.3M | $86.50M |
| YoY Change | 30.09% | 50.13% | 2.33% |
| Inventory | $257.5M | $246.4M | $266.6M |
| Prepaid Expenses | |||
| Receivables | $394.4M | $433.6M | $401.4M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $2.876B | $2.854B | $2.608B |
| YoY Change | 7.29% | 11.64% | 13.99% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $316.8M | $321.6M | $329.9M |
| YoY Change | -3.59% | -1.03% | 16.69% |
| Goodwill | $354.8M | ||
| YoY Change | 1.28% | ||
| Intangibles | $232.4M | ||
| YoY Change | -2.82% | ||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $116.8M | $115.4M | $120.4M |
| YoY Change | -8.18% | 3.06% | 12.75% |
| Total Long-Term Assets | $996.7M | $1.024B | $1.042B |
| YoY Change | -4.8% | -0.21% | 13.31% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $2.876B | $2.854B | $2.608B |
| Total Long-Term Assets | $996.7M | $1.024B | $1.042B |
| Total Assets | $3.873B | $3.878B | $3.650B |
| YoY Change | 3.9% | 8.24% | 13.79% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $64.00M | $65.70M | $73.20M |
| YoY Change | -1.69% | 1.14% | 22.43% |
| Accrued Expenses | $41.80M | $60.50M | $39.50M |
| YoY Change | -3.02% | 7.46% | 6.76% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $175.3M | $225.2M | $232.1M |
| YoY Change | -24.89% | 68.94% | 74.25% |
| Total Short-Term Liabilities | $538.5M | $581.6M | $584.4M |
| YoY Change | -9.43% | 19.29% | 22.55% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $1.310B | $1.240B | $1.100B |
| YoY Change | 12.93% | 4.2% | 0.0% |
| Other Long-Term Liabilities | $140.7M | $56.05M | $121.3M |
| YoY Change | 32.74% | 34.19% | 308.83% |
| Total Long-Term Liabilities | $1.451B | $1.402B | $1.221B |
| YoY Change | 14.59% | 5.24% | -2.6% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $538.5M | $581.6M | $584.4M |
| Total Long-Term Liabilities | $1.451B | $1.402B | $1.221B |
| Total Liabilities | $2.011B | $1.983B | $1.830B |
| YoY Change | 6.71% | 9.0% | 5.75% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $4.395B | ||
| YoY Change | 10.89% | ||
| Common Stock | $1.394B | ||
| YoY Change | 9.58% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $3.815B | ||
| YoY Change | 9.7% | ||
| Treasury Stock Shares | 74.33M shares | 73.57M shares | |
| Shareholders Equity | $1.862B | $1.895B | $1.819B |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $3.873B | $3.878B | $3.650B |
| YoY Change | 3.9% | 8.24% | 13.79% |
Cashflow Statement
| Concept | 2015 Q2 | 2014 Q4 | 2014 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $96.10M | $151.3M | $70.30M |
| YoY Change | -0.41% | 6.85% | -41.95% |
| Depreciation, Depletion And Amortization | $11.45M | $23.60M | $8.819M |
| YoY Change | -44.98% | 9.77% | 3.91% |
| Cash From Operating Activities | $154.6M | $161.7M | $115.8M |
| YoY Change | 45.44% | 12.84% | -9.42% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$21.40M | -$34.00M | -$21.40M |
| YoY Change | -6.14% | 32.3% | -30.07% |
| Acquisitions | $3.615M | ||
| YoY Change | |||
| Other Investing Activities | -$35.00M | -$45.60M | -$98.60M |
| YoY Change | 12.9% | -58.43% | 64.88% |
| Cash From Investing Activities | -$56.40M | -$79.60M | -$119.9M |
| YoY Change | 4.64% | -41.17% | 32.61% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $91.03M | $92.57M | |
| YoY Change | -8.68% | ||
| Debt Paid & Issued, Net | $100.0M | $1.295M | |
| YoY Change | -87.28% | ||
| Cash From Financing Activities | -60.30M | -2.400M | -$40.30M |
| YoY Change | 137.4% | -4.0% | 16.54% |
| NET CHANGE | |||
| Cash From Operating Activities | 154.6M | 161.7M | $115.8M |
| Cash From Investing Activities | -56.40M | -79.60M | -$119.9M |
| Cash From Financing Activities | -60.30M | -2.400M | -$40.30M |
| Net Change In Cash | 37.90M | 79.70M | -$44.49M |
| YoY Change | 40.37% | 1349.09% | -1709.73% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $154.6M | $161.7M | $115.8M |
| Capital Expenditures | -$21.40M | -$34.00M | -$21.40M |
| Free Cash Flow | $176.0M | $195.7M | $137.2M |
| YoY Change | 36.33% | 15.8% | -13.41% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-78705000 | USD |
| CY2014Q4 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
20397000 | USD |
| CY2014Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
3815203000 | USD |
| CY2014Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
56046000 | USD |
| CY2014Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
1401673000 | USD |
| CY2014Q4 | us-gaap |
Liabilities
Liabilities
|
1983268000 | USD |
| CY2014Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2014Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1567000 | USD |
| CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3877934000 | USD |
| CY2014Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
1392494000 | USD |
| CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
4394513000 | USD |
| CY2014Q4 | us-gaap |
Assets
Assets
|
3877934000 | USD |
| CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1894666000 | USD |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
422177000 | USD |
| CY2014Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
232371000 | USD |
| CY2014Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
433616000 | USD |
| CY2014Q4 | us-gaap |
Inventory Net
InventoryNet
|
246430000 | USD |
| CY2014Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
118302000 | USD |
| CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2853736000 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
321583000 | USD |
| CY2014Q4 | us-gaap |
Goodwill
Goodwill
|
354838000 | USD |
| CY2014Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
115406000 | USD |
| CY2015Q2 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
21313000 | USD |
| CY2015Q2 | wat |
Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
|
7002000 | USD |
| CY2015Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2015Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2015Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2015Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2015Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | shares |
| CY2015Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
157030000 | shares |
| CY2015Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
82701000 | shares |
| CY2014Q4 | wat |
Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
|
7179000 | USD |
| CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2015Q2 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
74329000 | shares |
| CY2014Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
2055000000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
|
415000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
283000 | USD |
| CY2014Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
96880000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
26578000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
144000 | USD |
| CY2015Q2 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
159000 | USD |
| CY2015Q2 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
1368000 | USD |
| CY2015Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8455000 | USD |
| CY2015Q2 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
2828000 | USD |
| CY2015Q2 | us-gaap |
Depreciation
Depreciation
|
11445000 | USD |
| CY2015Q2 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
11104000 | USD |
| CY2015Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-24802000 | USD |
| CY2015Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
21369000 | USD |
| CY2015Q2 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1776000 | USD |
| CY2015Q2 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
4891000 | USD |
| CY2015Q2 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-25518000 | USD |
| CY2015Q2 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
9367000 | USD |
| CY2015Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
154590000 | USD |
| CY2015Q2 | us-gaap |
Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
|
21410000 | USD |
| CY2015Q2 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
794422000 | USD |
| CY2015Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-56446000 | USD |
| CY2014Q1 | us-gaap |
Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
|
2647000 | USD |
| CY2014Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.82 | |
| CY2015Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.16 | |
| CY2015Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
28951000 | USD |
| CY2015Q2 | us-gaap |
Cost Of Services
CostOfServices
|
67293000 | USD |
| CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansBeforeTax
|
921000 | USD |
| CY2014Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
24746000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
|
-2000 | USD |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2015Q2 | us-gaap |
Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
|
2474000 | USD |
| CY2015Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2340000 | USD |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
156716000 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
83147000 | shares |
| CY2014Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
73569000 | shares |
| CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-59671000 | USD |
| CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
2651000 | USD |
| CY2014Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
1633211000 | USD |
| CY2015Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
17286000 | USD |
| CY2015Q2 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
121953000 | USD |
| CY2014Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
122475000 | USD |
| CY2014Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
126635000 | USD |
| CY2014Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
187719000 | USD |
| CY2014Q1 | us-gaap |
Gross Profit
GrossProfit
|
242789000 | USD |
| CY2014Q1 | us-gaap |
Interest Expense
InterestExpense
|
7489000 | USD |
| CY2014Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
12428000 | USD |
| CY2014Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1458000 | USD |
| CY2014Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
82730000 | USD |
| CY2014Q1 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
430508000 | USD |
| CY2014Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
70302000 | USD |
| CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
88761000 | USD |
| CY2014Q1 | us-gaap |
Cost Of Services
CostOfServices
|
65244000 | USD |
| CY2015Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
1.15 | |
| CY2014Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.83 | |
| CY2014Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
84977000 | shares |
| CY2015Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
83752000 | shares |
| CY2014Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.150 | pure |
| CY2015Q2 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
36390000 | USD |
| CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
-2026000 | USD |
| CY2015Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
-64348000 | USD |
| CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
|
-3057000 | USD |
| CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
|
116000 | USD |
| CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
|
-2136000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
|
931000 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
|
142000 | USD |
| CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
|
2767000 | USD |
| CY2015Q2 | wat |
Derivative Notional Amount1
DerivativeNotionalAmount1
|
109000000 | USD |
| CY2015Q2 | us-gaap |
Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-3006000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
512089000 | USD |
| CY2015Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-60274000 | USD |
| CY2015Q2 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-19249000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-40299000 | USD |
| CY2014Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-921000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-119949000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
607028000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
115755000 | USD |
| CY2014Q1 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
11523000 | USD |
| CY2014Q1 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
8507000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
395382000 | USD |
| CY2014Q1 | us-gaap |
Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
|
314000 | USD |
| CY2015Q2 | us-gaap |
Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
|
3348000 | USD |
| CY2015Q2 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
11000000 | USD |
| CY2014Q1 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
12000000 | USD |
| CY2015Q2 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
759386000 | USD |
| CY2015Q2 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Waters Corporation (“Waters</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">” or the “Company”) is</font><font style="font-family:Times New Roman;font-size:10pt;"> an analytical instrument manufacturer</font><font style="font-family:Times New Roman;font-size:10pt;"> that</font><font style="font-family:Times New Roman;font-size:10pt;"> primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (“HPLC”), ultra performance liquid chromatography (“UPLC</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">” and together with HPLC, referred to as “LC”) and mass spectrometry (“MS”) </font><font style="font-family:Times New Roman;font-size:10pt;">technology </font><font style="font-family:Times New Roman;font-size:10pt;">systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that </font><font style="font-family:Times New Roman;font-size:10pt;">are frequently employed </font><font style="font-family:Times New Roman;font-size:10pt;">together</font><font style="font-family:Times New Roman;font-size:10pt;"> (“LC-MS”)</font><font style="font-family:Times New Roman;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;">sold as integrated instrument systems using a common software platform</font><font style="font-family:Times New Roman;font-size:10pt;">. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS instruments are used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease process</font><font style="font-family:Times New Roman;font-size:10pt;">es (known as “proteomics”), nutritional</font><font style="font-family:Times New Roman;font-size:10pt;"> safety analysis and environmental testing. LC</font><font style="font-family:Times New Roman;font-size:10pt;">-MS</font><font style="font-family:Times New Roman;font-size:10pt;"> instruments </font><font style="font-family:Times New Roman;font-size:10pt;">combine </font><font style="font-family:Times New Roman;font-size:10pt;">a liquid phase sample introduction and separation system with mass spectrometric compound identification and quantification. Through its TA Division (“TA</font><font style="font-family:Times New Roman;font-size:10pt;">®</font><font style="font-family:Times New Roman;font-size:10pt;">”), the Company primarily designs, manufactures, sells and services thermal analysis, </font><font style="font-family:Times New Roman;font-size:10pt;">rheometry</font><font style="font-family:Times New Roman;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;">calorimetry</font><font style="font-family:Times New Roman;font-size:10pt;"> instruments, which are used in predicting the suitability</font><font style="font-family:Times New Roman;font-size:10pt;"> and stability</font><font style="font-family:Times New Roman;font-size:10pt;"> of fine chemicals,</font><font style="font-family:Times New Roman;font-size:10pt;"> pharmaceuticals, water,</font><font style="font-family:Times New Roman;font-size:10pt;"> polymers and viscous liquids for various industrial, consumer goods and healthcare products, as well as for life science research. The Company is also a developer and supplier of software-based products that interface with the Company's instruments</font><font style="font-family:Times New Roman;font-size:10pt;">, as well as other supplier</font><font style="font-family:Times New Roman;font-size:10pt;">s</font><font style="font-family:Times New Roman;font-size:10pt;">'</font><font style="font-family:Times New Roman;font-size:10pt;"> instruments,</font><font style="font-family:Times New Roman;font-size:10pt;"> and are typically purchased by customers as part of the instrument system.</font></p> | |
| CY2014Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
16749000 | USD |
| CY2014Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
144729000 | USD |
| CY2014Q4 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
4263000 | USD |
| CY2014Q4 | us-gaap |
Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
|
29000000 | USD |
| CY2014Q4 | us-gaap |
Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
|
3612000 | USD |
| CY2015Q2 | us-gaap |
Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
|
Cash equivalents represent highly liquid investments, with original maturities of 90 days or less, while investments with longer maturities are classified as investments. | |
| CY2015Q2 | wat |
Waters Restoration Plan Assets
WatersRestorationPlanAssets
|
35678000 | USD |
| CY2015Q2 | us-gaap |
Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
|
445000 | USD |
| CY2015Q2 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
631000 | USD |
| CY2015Q2 | us-gaap |
Other Cash Equivalents At Carrying Value
OtherCashEquivalentsAtCarryingValue
|
29000000 | USD |
| CY2015Q2 | us-gaap |
Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
|
3780000 | USD |
| CY2014Q4 | wat |
Waters Restoration Plan Assets
WatersRestorationPlanAssets
|
33935000 | USD |
| CY2014Q4 | us-gaap |
Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
|
123000 | USD |
| CY2014Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
1763320000 | USD |
| CY2014Q4 | us-gaap |
Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
|
651000 | USD |
| CY2015Q2 | wat |
Cash Equivalents And Investments Debt Maturities Next Rolling Twelve Months Fair Value
CashEquivalentsAndInvestmentsDebtMaturitiesNextRollingTwelveMonthsFairValue
|
897303000 | USD |
| CY2014Q4 | wat |
Derivative Notional Amount1
DerivativeNotionalAmount1
|
110000000 | USD |
| CY2015Q2 | wat |
Realized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
RealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-3348000 | USD |
| CY2015Q2 | wat |
Unrealized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
UnrealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
342000 | USD |
| CY2014Q1 | us-gaap |
Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-1195000 | USD |
| CY2014Q1 | wat |
Realized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
RealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-314000 | USD |
| CY2014Q1 | wat |
Unrealized Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net
UnrealizedGainLossOnForeignCurrencyDerivativesRecordedInEarningsNet
|
-881000 | USD |
| CY2015Q2 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
1762000 | USD |
| CY2015Q2 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
-2157000 | USD |
| CY2014Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
12795000 | USD |
| CY2014Q1 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
1752000 | USD |
| CY2014Q1 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
-1919000 | USD |
| CY2013Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
12962000 | USD |
| CY2015Q2 | wat |
Cash Equivalents And Investments Amortized Cost Basis
CashEquivalentsAndInvestmentsAmortizedCostBasis
|
1796472000 | USD |
| CY2015Q2 | wat |
Cash Equivalents And Investments Gross Unrealized Gains
CashEquivalentsAndInvestmentsGrossUnrealizedGains
|
2511000 | USD |
| CY2015Q2 | wat |
Cash Equivalents And Investments Gross Unrealized Losses
CashEquivalentsAndInvestmentsGrossUnrealizedLosses
|
-148000 | USD |
| CY2015Q2 | wat |
Cash Equivalents And Investments Fair Value
CashEquivalentsAndInvestmentsFairValue
|
1798835000 | USD |
| CY2014Q4 | wat |
Cash Equivalents And Investments Amortized Cost Basis
CashEquivalentsAndInvestmentsAmortizedCostBasis
|
1700666000 | USD |
| CY2014Q4 | wat |
Cash Equivalents And Investments Gross Unrealized Gains
CashEquivalentsAndInvestmentsGrossUnrealizedGains
|
441000 | USD |
| CY2014Q4 | wat |
Cash Equivalents And Investments Gross Unrealized Losses
CashEquivalentsAndInvestmentsGrossUnrealizedLosses
|
-845000 | USD |
| CY2014Q4 | wat |
Cash Equivalents And Investments Fair Value
CashEquivalentsAndInvestmentsFairValue
|
1700262000 | USD |
| CY2015Q2 | wat |
Cash Equivalents And Investments Debt Maturities Rolling Year Two Through Five Fair Value
CashEquivalentsAndInvestmentsDebtMaturitiesRollingYearTwoThroughFiveFairValue
|
837120000 | USD |
| CY2015Q2 | wat |
Debt Securities
DebtSecurities
|
1734423000 | USD |
| CY2014Q4 | wat |
Cash Equivalents And Investments Debt Maturities Next Rolling Twelve Months Fair Value
CashEquivalentsAndInvestmentsDebtMaturitiesNextRollingTwelveMonthsFairValue
|
872872000 | USD |
| CY2014Q4 | wat |
Cash Equivalents And Investments Debt Maturities Rolling Year Two Through Five Fair Value
CashEquivalentsAndInvestmentsDebtMaturitiesRollingYearTwoThroughFiveFairValue
|
763003000 | USD |
| CY2014Q4 | wat |
Debt Securities
DebtSecurities
|
1635875000 | USD |
| CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
44000000 | USD |
| CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
44000000 | USD |
| CY2015Q2 | us-gaap |
Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
|
-5000000 | USD |
| CY2015Q2 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
85943000 | USD |
| CY2015Q2 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
19513000 | USD |
| CY2015Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
152074000 | USD |
| CY2014Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
84952000 | USD |
| CY2015Q2 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
541407000 | USD |
| CY2014Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
574114000 | USD |
| CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
328299000 | USD |
| CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
341743000 | USD |
| CY2015Q2 | wat |
Intangible Assets Gross Foreign Currency Translation Adjustments
IntangibleAssetsGrossForeignCurrencyTranslationAdjustments
|
-42000000 | USD |
| CY2015Q2 | wat |
Intangible Assets Accumulated Amortization Foreign Currency Translation Adjustments
IntangibleAssetsAccumulatedAmortizationForeignCurrencyTranslationAdjustments
|
-24000000 | USD |
| CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
44000000 | USD |
| CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
44000000 | USD |
| CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
44000000 | USD |
| CY2014 | us-gaap |
Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
|
P8Y | |
| CY2015Q2 | us-gaap |
Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
|
P8Y | |
| CY2015Q2 | us-gaap |
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
|
-5000000 | USD |
| CY2015Q2 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
1485316000 | USD |
| CY2014Q4 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
1465243000 | USD |
| CY2015Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
1300000000 | USD |
| CY2014Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
19596000 | USD |
| CY2013Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
24716000 | USD |
| CY2015Q2 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
20529000 | USD |
| CY2014Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
23904000 | USD |
| CY2015Q2 | wat |
Other Changes In Uncertain Tax Benefits
OtherChangesInUncertainTaxBenefits
|
933000 | USD |
| CY2014Q1 | wat |
Other Changes In Uncertain Tax Benefits
OtherChangesInUncertainTaxBenefits
|
-812000 | USD |
| CY2015Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
8455000 | USD |
| CY2014Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
8129000 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
32000 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
|
0 | USD |
| CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.016 | pure |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.019 | pure |
| CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.267 | pure |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.245 | pure |
| CY2015Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y | |
| CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y | |
| CY2015Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
113.88 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
99.22 | |
| CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
26.94 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
22.38 | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3280000 | shares |
| CY2015Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
-135000 | shares |
| CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
-72000 | shares |
| CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3105000 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
82.85 | |
| CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
83.25 | |
| CY2015Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
75.50 | |
| CY2015Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
83.48 | |
| CY2015Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
727000 | shares |
| CY2015Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
600000 | shares |
| CY2014Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
600000 | shares |
| CY2014Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
896000 | shares |
| CY2015Q2 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | pure |
| CY2015Q2 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | pure |
